Michael Morris, MD [clinicaltrials_resource:ff2bdbbb939fe869c0446bcfe9118d41]
Chemotherapy in Treating Patients With Solid Tumors [clinicaltrials:NCT00003103]Calcitriol and Zoledronate in Treating Patients With Progressive Prostate Cancer [clinicaltrials:NCT00004928]Testosterone in Treating Patients With Progressive Prostate Cancer That No Longer Responds to Hormone Therapy [clinicaltrials:NCT00006044]Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer [clinicaltrials:NCT00024232]Ixabepilone With or Without Estramustine in Treating Patients With Progressive Prostate Cancer [clinicaltrials:NCT00025194]Radiolabeled Monoclonal Antibody in Treating Patients With Progressive Metastatic Androgen-Independent Adenocarcinoma (Cancer) of the Prostate [clinicaltrials:NCT00081172]
overall official [clinicaltrials_vocabulary:overall-official]
Michael Morris, MD [clinicaltrials_resource:ff2bdbbb939fe869c0446bcfe9118d41]
Bio2RDF identifier
ff2bdbbb939fe869c0446bcfe9118d41
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:ff2bdbbb939fe869c0446bcfe9118d41
affiliation [clinicaltrials_vocabulary:affiliation]
last name [clinicaltrials_vocabulary:last-name]
Michael Morris, MD
role [clinicaltrials_vocabulary:role]
Study Chair
identifier
clinicaltrials_resource:ff2bdbbb939fe869c0446bcfe9118d41
title
Michael Morris, MD
@en
type
label
Michael Morris, MD [clinicaltrials_resource:ff2bdbbb939fe869c0446bcfe9118d41]
@en